Determination of the Degree of Esterification in Heparin Benzylates During Synthesis of Enoxaparin, a Domestic Analog of Low-Molecular-Mass Heparin


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The esterification stage of low-molecular-mass heparin (enoxaparin) production by hydrolytic depolymerization of unfractionated heparin was studied and consisted of treating previously synthesized benzethonium heparinate with benzyl chloride. The content of benzyl moieties in the synthesized heparin benzylates and their degree of benzylation were determined using HPLC, PMR, and 13C NMR methods. A carboxylic-acid content of 0.13 ± 0.01 mol/g in the starting heparin was calculated from these results. A new method for estimating the degree of heparin benzylation from PMR and HPLC data was proposed. The benzyl content in the heparin benzylates increased with increasing molar excess of benzyl chloride.

Авторлар туралы

L. Frumin

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454

K. Yur’eva

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Хат алмасуға жауапты Автор.
Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454

A. Matveev

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454

E. Vorfolomeeva

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

I. Vostrov

Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Ресей, Skolkovo, Moscow, 121353

G. Zatonskii

G. F. Gause Institute of New Antibiotics

Email: kristina.yureva1994@mail.ru
Ресей, 11 Bol’shaya Pirogovskaya St., Moscow, 119435

D. Prokhorov

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454

E. Zhavoronok

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

A. Panov

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

L. Grebenkina

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454

N. Pyatigorskaya

I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: kristina.yureva1994@mail.ru
Ресей, Moscow

G. Brkich

I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: kristina.yureva1994@mail.ru
Ресей, Moscow

S. Kedik

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Ресей, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2019